Anzeige
Mehr »
Login
Montag, 27.01.2025 Börsentäglich über 12.000 News von 683 internationalen Medien
US-Präsident setzt auf die Solana Blockchain! Diese Krypto-Perle profitiert enorm!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
299 Leser
Artikel bewerten:
(1)

Daniels Health: Sharpsmart Ltd. Announces Initiatives Designed to Reset the Standard for Clinical Waste Management in the UK

Finanznachrichten News

LONDON, Sept. 7, 2021 /PRNewswire/ -- Sharpsmart, a subsidiary of Daniels Corporation International Pty Ltd, today announced the completion of several initiatives implemented over the last 18 months. Following these actions, the company has transitioned to become a full-service, integrated provider of healthcare waste management, supporting its NHS customers during a period of unprecedented industry service disruptions and driving new national sustainability and safety standards. These efforts include:

  • The acquisition of two clinical waste treatment facilities that provided much needed contingency to support clinical waste clearance and ensure healthcare providers met their patients' needs.

  • Compliance with new global ISO safety standards for reusable sharps containers to protect from needlestick injuries. Sharpsmart is currently the only provider of reusable containers in the UK to meet the ISO 23907 Part 2 standard.

  • Development of an innovative, patented, R-Coded non-incineration treatment process for sharps disposal. This first-of-its-kind treatment technology significantly reduces carbon emissions associated with high temperature incineration of healthcare-generated sharps, providing considerable environmental benefits over alternative methods.

  • Introduction of a new range of reusable clinical waste containers (adding to its sharps container range) in order to provide further sustainable alternatives to single-use clinical waste disposal and to support the introduction of its healthcare metals recovery programme.

  • Expansion of capacities at two existing reusable sharps processing centres to support increased demand for reusable sharps systems from NHS customers.

"Over the last 18 months, Sharpsmart has evolved to meet the unprecedented challenges of the moment," said Neil Robinson, Managing Director for Sharpsmart. "When the clinical waste industry was in crisis, we knew it was critical to not just provide continuity of service, but support healthcare providers with our Inside-the-Four-Walls method that uniquely emphasises our NHS partnership approach, communication, and collaboration in order to reduce costs, support the NHS's 'Route-to-Net-Zero' Strategy, and improve healthcare worker and patient safety."

"Throughout the COVID-19 pandemic, we have been proud to continue meeting the needs of healthcare providers without interruption, and through it all, we have enhanced the process with new facilities, new products, and new treatment methods that align with national approaches to resilience and sustainability."

Taken together, these initiatives are designed to reset the standard for healthcare waste management in the UK in order to improve service reliability, clinician safety, compliance standards, and environmental sustainability. To learn more about Sharpsmart's approach to healthcare waste management as well as its benchmarking of a New Normal in safety, infection control, and service protocols, visit here.

About Sharpsmart

Sharpsmart entered the UK healthcare market in 2000 as the safe clinical alternative for sharps management. Challenging the long-instilled practices of sharps and clinical waste being managed as a service that included no clinical or healthcare worker safety value, Sharpsmart ushered in a new standard of risk prevention by putting inherent safety, intelligent movement, and clinical design at the forefront of point of care sharps and infectious waste management practices.

With a national service infrastructure that supports hospitals across the United Kingdom, and years of collective experience and expertise in the clinical space, Sharpsmart is the unrivalled expert in infection risk reduction, sharps and infectious waste management solutions. In 21 years of servicing over 100 acute hospitals and thousands of other healthcare service providers, Sharpsmart has earned itself the reputation of not simply a "provider" of solutions, but a true "partner" to the NHS.

© 2021 PR Newswire
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.